A randomized phase II trial of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin in previously untreated patients with advanced gastric cancer

Trial Profile

A randomized phase II trial of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin in previously untreated patients with advanced gastric cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cisplatin; Docetaxel; Oxaliplatin
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Sep 2009 Results for 75 patients were presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology (ECCO/ESMO 2009)
    • 02 Jun 2009 Results for 61 patients were presented at the 45th Annual Meeting of the American Society of Clinical Oncology.
    • 15 Jan 2009 Results for 51 patients were presented at the 2009 Gastrointestinal Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top